Information about Inhaled Version of PD medication


 Levodopa pill can wear off, but a powdered version can come to the rescue, study finds.      

WEDNESDAY, Oct. 12, 2016 (HealthDay News) — An inhaled version of the Parkinson’s drug levodopa can help when patients experience symptoms between doses of the pill form of the medication, a new, small study finds.

Levodopa can control the tremors, rigidity and difficulty maintaining balance and coordination associated with Parkinson’s disease. However, within two years, as many as half of all patients have rapid and unexpected loss of motor control during “off” periods, when the drug wears off between doses, the researchers explained.

“Off periods are considered one of the greatest unmet medical needs in the treatment of Parkinson’s, and typically increase in frequency during the course of the disease,” said lead researcher Michael Lipp. He is vice president of pharmaceutical development and technical operations at Acorda Therapeutics, the drug’s maker and funder of the study.

Inhaled levodopa could be used along with oral levodopa by the 70 percent of Parkinson’s patients in the United States who take it, he said.

“We’re studying inhaled levodopa to determine the extent to which it can restore motor function when used as people begin to experience off periods,” Lipp said.

In clinical trials, patients were able to use the inhaler themselves while in an off state, he said. More testing and larger trials are needed before powered levodopa could be available.

“Off periods can be hugely disruptive to the lives of people with Parkinson’s and their families,” Lipp said. “Inhaled levodopa has the potential to help people with Parkinson’s minimize these disruptions.”

Dr. Michael Okun is the national medical director of the National Parkinson Foundation. “A delayed response for medications to kick in and start working is a huge issue for many of our patients who call the Parkinson’s Foundation helpline,” he said.

“The inhaled levodopa formulation could potentially help these people and we look forward to larger studies focused on people” who struggle with these off periods, Okun said.

For the study, Lipp and colleagues tested the powered version of levodopa in dogs, 18 people without Parkinson’s and 24 Parkinson’s patients who had at least two off hours a day despite taking levodopa pills.

The inhaled drug was rapidly absorbed and was detectable in the bloodstream within five minutes, compared with 20 minutes after taking levodopa orally, the researchers found.

Parkinson’s patients showed improved motor function after inhaling the drug, Lipp said. The drug appeared safe and was well-tolerated. Coughing was the most common side effect, according to the study.

The report was published Oct. 12 in the journal Science Translational Medicine.

There are approximately 1 million people in the United States with Parkinson’s disease, according to the researchers. A progressive neurodegenerative disorder caused by the gradual loss of certain brain cells responsible for producing dopamine, Parkinson’s causes impairment of motor function, including impaired movement, muscle stiffness and tremors.

Other symptoms include anxiety, depression, sleep difficulties and stomach problems, the researchers said.

In the United States, about 350,000 people with Parkinson’s have off periods, the researchers added.

Dr. Andrew Feigin is a neurologist at the Northwell Health Neuroscience Institute in Great Neck, N.Y. “Levodopa remains the gold standard treatment for Parkinson’s disease, but the beneficial effects of it may become erratic and unreliable as Parkinson’s progresses,” he said.

Several new preparations of levodopa have either recently become available or are in development, he said. “Currently, the only rescue medication for these dose failures is an injectable dopamine agonist called Apokyn [apomorphine], so having an inhaled drug that can fill this need would be helpful,” Feigin said.

SOURCES: Michael Lipp, Ph.D., vice president, pharmaceutical development and technical operations, Acorda Therapeutics, Chelsea, Mass.; Michael Okun, M.D., national medical director, National Parkinson Foundation; Andrew Feigin, M.D., neurologist, Northwell Health’s Neuroscience Institute, Great Neck, N.Y.; Oct. 12, 2016,                                         Science Translational Medicine

HealthDay   Copyright (c) 2016 HealthDay. All rights reserved.


Leave a Reply

Donation Information

I would like to make a donation in the amount of:


I would like this donation to automatically repeat each month

Tribute Gift

Check here to donate in honor or memory of someone

Donor Information

First Name:
Last Name:
Add me to your mailing list

Donor Address

Address 2:(optional)
State :
Postal Code:

Shop with AmazonSmile and Support The NeuroCommunity Foundation

Did you know that you can support The NeuroCommunity Foundation through your everyday online purchases? has a charitable program called AmazonSmile. It is a simple and automatic way for you to support The NeuroCommunity Foundation every time you shop, at no cost to you.

When you shop at AmazonSmile, you’ll find the exact same low prices, vast selection and convenient shopping experience as, with the added bonus that the AmazonSmile Foundation will donate 0.5% of the purchase price to The NeuroCommunity Foundation!

It’s simple:

1) Go to AmazonSmile from the web browser on your computer or mobile device.
2)Login with your username and password or create one if you are a new user.
3) Search for The NeuroCommunity Foundation in the search box on the right side where it asks which charity you would like to support.
4) Select The NeuroCommunity Foundation from the search results or type in The NeuroCommunity Foundation should the select not include our organization.
Happy shopping and thank you for supporting The NeuroCommunity Foundation

Support us when you shop for back-to-school items.

Just Click Here and Shop

Northridge Foundation For Neurological Research & Education

Smile with Back to School shopping

Dear The NeuroCommunity Foundation friends,supporters and participants.

If you happen to shop at Ralphs and would like to support The NeuroCommunity Foundation, we would be most appreciative!. If you do shop at Ralphs, we will receive 1 % of your purchase through their community
contribution program. The NeuroCommunity Foundation's Non-Profit Org. number ( NP0 # ) is 82287

All you need to do is enroll online at OR by calling Ralphs at
800-443-4438 after September 1, 2016.

If you happened to enroll prior to Sept 1st, Ralphs requires you to register again.

For your convenience, step-by-step website registration instructions are found below or can be found at, click on Community, click on Community Contributions, click on ‘Enroll Now’. If you don’t have computer access, please call us at 1-800-443-4438 for assistance.

Use you Ralph’s Rewards Card to Contribute Here’s How:

If you do not have a Ralph’s online account
1. Go to
2. Follow the easy steps to create an online account
3. You will be instructed to go to your email inbox to confirm your account
4. After you confirm your online account by clicking on the link in your email, return to and click on ‘Sign In’, enter your email address and password.
5. View all your information and edit as necessary
6. Link your card to your organization by clicking on:
a. Community Rewards – Enroll
b. Type our NPO number 82287 or
c. Remember to click on the circle to the left of your organizations’ name
d. Click on Enroll to finish your enrollment process

(This means that you have already entered your email address and assigned yourself a password)

1. Log in to
2. Click Sign In
3. Enter your email address and password
4. Click on ‘Your Name’ (In the top right hand corner)
5. View all your information and edit as necessary
6. Link your card to your organization by clicking on:
a. Community Rewards – Re-Enroll
b. Type your NPO number or Name of your Organization
c. Remember to click on the circle to the left of your organizations’ name
d. Click on Enroll to finish your enrollment process